Micro dosing pumps used worldwide against COVID-19

HNPM offers solutions with dosing volumes from 0.25 µl.

Automated analysis equipment is the essential basis for extensive testing capabilities for the corona virus. Through parallel and faster processes, automation significantly increases the number of tests, saves manpower and ensures process reliability.

For sample preparation for SARS-CoV-2, a few microliters of a solution of chemicals and enzymes are dosed. Micropumps from HNPM perform these demanding tasks with high accuracy in a reliable process. The minimum dosing volume is 0.25 µl. The pumps have a very small footprint and can easily be built into control systems. Fully automated analysis equipment can contain up to 16 dosing pumps and process up to 4,000 samples per 24 hours.

Micro dosing pumps are also used in research into vaccines and therapies against COVID-19. Every development step in university research institutes, in international pharmaceutical companies or in start-ups worldwide is accompanied by numerous laboratory tests. This is a huge task, which is also done automatically.

Micropumps from different series, such as the hermetically sealed, inert pumps from HNPM, are used in the production of vaccines. From diagnostics and research to future vaccine production, micropumps can be used in the fight against COVID-19. In applications where small and very small quantities of liquids need to be delivered with high precision, mzr pumps from HNP Mikrosysteme provide precise solutions and guarantee process reliability.

HNP Microsysteme

The German company HNP Mikrosysteme GmbH develops, produces and sells pumps and systems worldwide that can deliver small volumes of liquids quickly and accurately. In addition to various applications in plant engineering, chemical and pharmaceutical processing, mzr pumps are used in the field of life science and analytical instrumentation.

HNP Microsysteme is represented in the Netherlands and Belgium by Suurmond.